APA (7th ed.) Citation

D, M., R, A., D, C., L, C., C, C., F, I., . . . V, F. (2026). Evolution of Janus Kinase inhibitors (JAKi) prescriptions since 2015 in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study): Effect of regulatory warnings. Seminars in arthritis and rheumatism, 77, 152946. https://doi.org/10.1016/j.semarthrit.2026.152946

Chicago Style (17th ed.) Citation

D, Mongin, et al. "Evolution of Janus Kinase Inhibitors (JAKi) Prescriptions Since 2015 in an International Collaboration of Rheumatoid Arthritis Registers (the 'JAK-pot' Study): Effect of Regulatory Warnings." Seminars in Arthritis and Rheumatism 77 (2026): 152946. https://doi.org/10.1016/j.semarthrit.2026.152946.

MLA (9th ed.) Citation

D, Mongin, et al. "Evolution of Janus Kinase Inhibitors (JAKi) Prescriptions Since 2015 in an International Collaboration of Rheumatoid Arthritis Registers (the 'JAK-pot' Study): Effect of Regulatory Warnings." Seminars in Arthritis and Rheumatism, vol. 77, 2026, p. 152946, https://doi.org/10.1016/j.semarthrit.2026.152946.